Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Levels and Rates of Physical Activity in Older Adults with Multiple Sclerosis.
Multifocal inflammatory demyelination in a patient with rheumatoid arthritis and treatment complications.
Contribution of mast cells to injury mechanisms in a mouse model of pediatric traumatic brain injury.
Heterogeneous depression trajectories in multiple sclerosis patients.
Prevalence of Cytomegalovirus in Patients With Multiple Sclerosis: A Case-Control Study in Northern Iran.
The payer's perspective: What is the burden of MS and how should the patient's perspective be integrated in health technology assessment conducted for taking decisions on access to care and treatment?
Subjective and objective knowledge and decisional role preferences in cerebrovascular patients compared to controls.
Maternal chewing during prenatal stress ameliorates stress-induced hypomyelination, synaptic alterations, and learning impairment in mouse offspring.
T lymphocyte apoptosis in systemic lupus erythematosus patients.
The Swedish version of the Acceptance of Chronic Health Conditions Scale for people with multiple sclerosis: translation, cultural adaptation and psychometric properties.
Autoinjector preference in multiple sclerosis and the role of nurses in treatment decisions: results from an international survey in Europe and the USA.
Baseline predictors of persistence to first disease-modifying treatment in multiple sclerosis.
Targeting the Nrf2-Heme Oxygenase-1 Axis after Intracerebral Hemorrhage.
The comparison of selected cerebrospinal fluid and serum cytokine levels in patients with multiple sclerosis and normal pressure hydrocephalus.
A review of the ethics of the use of placebo in clinical trials for relapsing-remitting multiple sclerosis therapeutics.
Scrub Typhus Causing Unilateral Optic Neuritis.
Novel Histopathological Patterns in Cortical Tubers of Epilepsy Surgery Patients with Tuberous Sclerosis Complex.
Multiple sclerosis and primary vascular dysregulation (Flammer syndrome).
Endogenous hypothermic response to hypoxia reduces brain injury: Implications for modeling hypoxic-ischemic encephalopathy and therapeutic hypothermia in neonatal mice.
Herpes Simplex Acute Retinal Necrosis Presenting as Unilateral Disc Swelling in Young Immunocompetent Patients.
Money Management Activities in Persons with Multiple Sclerosis.
Magnetic resonance imaging assessment of degenerative cervical myelopathy: a review of structural changes and measurement techniques.
Propensity methods for multiple sclerosis: The devil is in the details.
Increase of Alternatively Activated Antigen Presenting Cells in Active Experimental Autoimmune Encephalomyelitis.
MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance.
Pages
« first
‹ previous
…
787
788
789
790
791
792
793
794
795
…
next ›
last »